Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.850
+0.010 (0.26%)
Sep 18, 2026, 4:08 PM HKT

HKG:2591 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
153.28131.51--
Revenue Growth
171.55%---
Cost of Revenue
30.0414.45--
Gross Profit
123.24117.06--
Selling, General & Admin
267.71254.0586.85255.74
Research & Development
191.99205.78102.51492.11
Other Operating Expenses
24.344.110.060.06
Operating Expenses
484.03463.93189.42747.91
Operating Income
-360.8-346.87-189.42-747.91
Interest Expense
-3.86-1.72-0.87-2.32
Interest & Investment Income
18.2913.514.813.97
Currency Exchange Gain (Loss)
-6.45-6.450.70.71
Other Non Operating Income (Expenses)
16.760.180.211.05
EBT Excluding Unusual Items
-336.05-341.36-174.58-734.5
Gain (Loss) on Sale of Investments
1.7-0.191.13
Gain (Loss) on Sale of Assets
---4.45-
Other Unusual Items
--4.15-
Pretax Income
-334.35-341.36-174.69-733.38
Net Income
-334.35-341.36-174.69-733.38
Net Income to Common
-334.35-341.36-174.69-733.38
Net Income Growth
----
Shares Outstanding (Basic)
452434420383
Shares Outstanding (Diluted)
452434420383
Shares Change
7.64%3.44%9.63%-
EPS (Basic)
-0.74-0.79-0.42-1.92
EPS (Diluted)
-0.74-0.79-0.42-1.92
EPS Growth
----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-362.45-315.51-166.57-176.64
Free Cash Flow Per Share
-0.80-0.73-0.40-0.46
Gross Margin
80.40%89.01%--
Operating Margin
-235.38%-263.76%--
Profit Margin
-218.13%-259.57%--
Free Cash Flow Margin
-236.46%-239.91%--
EBITDA
-352.53-339.71-174.91-733.76
EBITDA Margin
-229.99%-258.32%--
D&A For EBITDA
8.267.1614.5114.14
EBIT
-360.8-346.87-189.42-747.91
EBIT Margin
-235.38%-263.76%--